Mode
Text Size
Log in / Sign up

ganciclovir

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ganciclovir

8 trials tracked of ganciclovir: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 76 citations.

8Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 5 Phase 2 3
  1. Phase 3 Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir Completed · 76 cited
  2. Phase 3 A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation Completed · 64 cited
  3. Phase 3 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed
  4. Phase 3 Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients Completed
  5. Phase 3 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed
  6. Phase 2 Islet Transplantation for Type 1 Diabetes Completed
Show 2 more trials
  1. Phase 2 Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant Completed
  2. Phase 2 Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.